T 0240/16 (Lipid fraction for use in the support of the brain function /NUTRICIA) of 04.02.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T024016.20210204
- Date of decision
- 4 February 2021
- Case number
- T 0240/16
- Petition for review of
- -
- Application number
- 11195555.5
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Lipid composition for improving brain function
- Applicant name
- N.V. Nutricia
- Opponent name
- Fresenius Kabi Deutschland GmbH
ABBOTT LABORATORIES
Société des Produits Nestlé S.A. - Board
- 3.3.09
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a) (2007)European Patent Convention Art 100(c) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention Art 123(3) (2007)European Patent Convention Art 53(c) (2007)European Patent Convention Art 54(5) (2007)European Patent Convention Art 76(1) (2007)European Patent Convention Art 84 (2007)Rules of procedure of the Boards of Appeal Art 11 (2020)Rules of procedure of the Boards of Appeal Art 12(2) (2020)Rules of procedure of the Boards of Appeal Art 12(4) (2007)
- Keywords
- Main request - admission into the appeal proceedings (no)
Auxiliary request 1 - admission into the appeal proceedings (yes)
Auxiliary request 1 - added subject-matter and extension of scope of protection (no) - Clarity (yes)
Auxiliary request 1 - claimed subject-matter limited to a therapeutic application (yes) - Novelty (yes)
Remittal to the opposition division (yes) - Catchword
- -
- Citing cases
- T 0197/24
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.